Consolidated Financial Results for the Fiscal Year Ended January 31, [Japanese GAAP]

Transcription

1 Consolidated Financial Results for the Fiscal Year Ended January 31, 2019 [Japanese GAAP] March 15, 2019 Company name: Tri Chemical Laboratories Inc. Stock exchange listing: Tokyo Stock Exchange Code number: 4369 URL: Representative: Kiyoshi Tazuke, President Contact: Hisakatsu Sugawara, Senior Executive Director Phone: Scheduled date of Annual General Meeting of Shareholders: April 25, 2019 Scheduled date of filing annual securities report: April 26, 2019 Scheduled date of commencing dividend payments: April 26, 2019 Availability of supplementary briefing material on annual financial results: Not available Schedule of annual financial results briefing session: Scheduled (for institutional investors and analysts) (Amounts of less than one million yen are rounded down.) 1. Consolidated Financial Results for the Fiscal Year Ended January 31, 2019 (February 1, 2018 to January 31, 2019) (1) Consolidated Operating Results (cumulative) (% indicates changes from the previous corresponding.) Net sales Operating profit Ordinary profit Profit attributable to owners of parent Fiscal year ended Million yen % Million yen % Million yen % Million yen % January 31, ,792-2,153-2,931-2,267 - January 31, (Note) Comprehensive income: Fiscal year ended January 31, 2019: 2,173 million ( - %) Fiscal year ended January 31, 2018: - million ( - %) Basic earnings Diluted earnings Rate of return Ordinary profit to Operating profit per share per share on equity total assets to net sales Fiscal year ended Yen Yen % % % January 31, January 31, (Reference) Equity in earnings of affiliated companies: Fiscal year ended January 31, 2019: 826 million Fiscal year ended January 31, 2018: - million (Note) Since the Company began preparing consolidated financial statements from the fiscal year ended January 31, 2019, figures for the fiscal year ended January 31, 2018, and year-on-year changes are not shown above. (2) Consolidated Financial Position Total assets Net assets Equity ratio Net assets per share Million yen Million yen % Yen As of January 31, ,112 7, As of January 31, (Reference) Equity: As of January 31, 2019: 7,025 million As of January 31, 2018: - million (Note) Since the Company began preparing consolidated financial statements from the fiscal year ended January 31, 2019, figures as of January 31, 2018 are not shown above.

2 (3) Consolidated Cash Flows Cash and cash Cash flows from Cash flows from Cash flows from operating activities investing activities financing activities equivalents at end of Fiscal year ended Million yen Million yen Million yen Million yen January 31, ,411 (1,244) 269 1,595 January 31, (Note) Since the Company began preparing consolidated financial statements from the fiscal year ended January 31, 2019, figures as of January 31, 2018 are not shown above. 2. Dividends 1st quarter-end 2nd quarter-end Annual dividends 3rd quarter-end Year-end Total Total dividends Payout ratio (consolidated) Dividends to net assets (consolidated) Fiscal year ended Yen Yen Yen Yen Yen Million yen % % January 31, January 31, Fiscal year ending January 31, 2020 (Forecast) (Note) Since the Company began preparing consolidated financial statements from the fiscal year ended January 31, 2019, payout ratio and dividends to net assets for the fiscal year ended January 31, 2018 are not shown above. 3. Consolidated Financial Results Forecast for the Fiscal Year Ending January 31, 2020 (February 1, 2019 to January 31, 2020) (% indicates changes from the previous corresponding.) Net sales Operating profit Ordinary profit Profit attributable Basic earnings to owners of parent per share Million yen % Million yen % Million yen % Million yen % Yen First half 4, ,020 (2.2) 1, , Full year 8, , , ,

3 * Notes: (1) Changes in significant subsidiaries during the under review: No (Changes in specific subsidiaries due to changes in the scope of consolidation) New: - companies (company name), excluded: - companies (company name) (2) Changes in accounting policies, changes in accounting estimates and retrospective restatement 1) Changes in accounting policies due to the revision of accounting standards: No 2) Changes in accounting policies other than 1) above: No 3) Changes in accounting estimates: No 4) Retrospective restatement: No (3) Total number of issued shares (common shares) 1) Total number of issued shares at the end of the (including treasury shares): January 31, 2019: 7,812,160 shares January 31, 2018: 7,812,160 shares 2) Total number of treasury shares at the end of the : January 31, 2019: 306 shares January 31, 2018: 200 shares 3) Average number of shares during the : Fiscal year ended January 31, 2019: 7,811,932 shares Fiscal year ended January 31, 2018: 7,812,012 shares * These financial results are outside the scope of audit by certified public accountants or an audit firm. * Explanation of the proper use of financial results forecast and other notes The earnings forecasts and other forward-looking statements herein are based on information currently available to the Company and certain assumptions deemed reasonable, and do not represent a commitment by the Company that they will be achieved. Actual results may differ significantly from these forecasts due to a wide range of factors. The Company plans to hold a financial results briefing for institutional investors and analysts on March 20, Financial results materials to be used at the briefing will be available on the Company s website immediately after the session.

4 Consolidated Financial Statements (1) Consolidated Balance Sheets As of January 31, 2019 Assets Current assets Cash and deposits 1,595,747 Notes and accounts receivable - trade 1,808,824 Electronically recorded monetary claims - operating 1,042,313 Merchandise and finished goods 53,020 Work in process 395,790 Raw materials and supplies 484,061 Deferred tax assets 46,835 Other 57,599 Total current assets 5,484,191 Non-current assets Property, plant and equipment Buildings and structures 2,569,990 Accumulated depreciation 916,646) Buildings and structures, net 1,653,343 Machinery, equipment and vehicles 1,876,986 Accumulated depreciation 1,018,965) Machinery, equipment and vehicles, net 858,020 Tools, furniture and fixtures 1,738,753 Accumulated depreciation 1,186,029) Tools, furniture and fixtures, net 552,724 Land 608,641 Leased assets 39,246 Accumulated depreciation 8,336) Leased assets, net 30,910 Construction in progress 240,383 Total property, plant and equipment 3,944,024 Intangible assets 70,211 Investments and other assets Investment securities 1,595,054 Other 19,448 Total investments and other assets 1,614,502 Total non-current assets 5,628,739 Total assets 11,112,931 1

5 As of January 31, 2019 Liabilities Current liabilities Accounts payable - trade 353,684 Short-term loans payable 580,000 Current portion of long-term loans payable 712,880 Lease obligations 5,659 Income taxes payable 401,650 Deferred tax liabilities 246 Provision for bonuses 63,857 Other 450,968 Total current liabilities 2,568,947 Non-current liabilities Long-term loans payable 1,377,839 Lease obligations 28,174 Deferred tax liabilities 17,996 Net defined benefit liability 94,188 Total non-current liabilities 1,518,198 Total liabilities 4,087,145 Net assets Shareholders equity Capital stock 808,912 Capital surplus 709,912 Retained earnings 5,550,282 Treasury shares 897) Total shareholders equity 7,068,210 Accumulated other comprehensive income Valuation difference on available-for-sale securities 4,399) Foreign currency translation adjustments 9,382) Remeasurements of defined benefit plans 28,642) Total accumulated other comprehensive income 42,424) Total net assets 7,025,785 Total liabilities and net assets 11,112,931 2

6 (2) Consolidated Statements of Income and Comprehensive Income Consolidated Statements of Income For the fiscal year ended January 31, 2019 Net sales 7,792,295 Cost of sales 4,200,456 Gross profit 3,591,839 Selling, general and administrative expenses 1,438,666 Operating profit 2,153,173 Non-operating income Interest income 104 Dividend income 286 Share of profit of entities accounted for using equity method 826,688 Other 28,370 Total non-operating income 855,450 Non-operating expenses Interest expenses 11,983 Foreign exchange losses 27,149 Commission for syndicated loans 30,000 Other 7,810 Total non-operating expenses 76,942 Ordinary profit 2,931,680 Profit before income taxes 2,931,680 Income taxes - current 623,529 Income taxes - deferred 40,927 Total income taxes 664,457 Profit 2,267,222 Profit attributable to owners of parent 2,267,222 3

7 Consolidated Statements of Comprehensive Income For the fiscal year ended January 31, 2019 Profit 2,267,222 Other comprehensive income Valuation difference on available-for-sale securities 7,722) Foreign currency translation adjustments 18,005) Remeasurements of defined benefit plans, net of tax 12,051) Share of other comprehensive income of entities accounted for using equity method 56,276) Total other comprehensive income 94,056) Comprehensive income 2,173,166 Comprehensive income attributable to Comprehensive income attributable to owners of parent 2,173,166 Comprehensive income attributable to non-controlling interests - 4

8 (3) Consolidated Statements of Changes in Net Assets For the fiscal year ended January 31, 2019 Balance at beginning of current Changes of items during Capital stock Capital surplus Shareholders' equity Retained earnings Treasury shares Total shareholders equity 808, ,912 3,447, ) 4,965,514 Dividends of surplus 164,051) 164,051) Profit attributable to owners of parent Purchase of treasury shares Net changes of items other than shareholders' equity Total changes of items during Balance at end of current 2,267,222 2,267, ) 475) - - 2,103, ) 2,102, , ,912 5,550, ) 7,068,210 Balance at beginning of current Changes of items during Dividends of surplus Profit attributable to owners of parent Purchase of treasury shares Net changes of items other than shareholders' equity Total changes of items during Balance at end of current Valuation difference on available-for-sale securities Accumulated other comprehensive income Accumulated Foreign Remeasurements currency of defined translation benefit plans, adjustments net of tax Total accumulated other comprehensive income Total net assets 3,323 64,898 16,590) 51,631 5,017, ,051) 2,267, ) 7,722) 74,281) 12,051) 94,056) 94,056) 7,722) 74,281) 12,051) 94,056) 2,008,639 4,399) 9,382) 28,642) 42,424) 7,025,785 5

9 (4) Consolidated Statements of Cash Flows For the fiscal year ended January 31, 2019 Cash flows from operating activities Profit before income taxes 2,931,680 Depreciation 483,929 Increase (decrease) in provision for bonuses 2,464 Interest and dividend income 391) Interest expenses 11,983 Share of loss (profit) of entities accounted for using equity method 826,688) Decrease (increase) in notes and accounts receivable - trade 486,526) Decrease (increase) in inventories 97,047) Increase (decrease) in notes and accounts payable - trade 31,157) Decrease/increase in consumption taxes receivable/payable 11,294 Increase (decrease) in accounts payable - other 22,111) Decrease (increase) in other current assets 22,307 Increase (decrease) in other current liabilities (5,079) Increase (decrease) in other non-current liabilities 24,101 Other, net 19,846) Subtotal 1,998,913 Interest and dividend income received 391 Interest expenses paid 11,948) Income taxes paid 576,065) Net cash provided by (used in) operating activities 1,411,291 Cash flows from investing activities Purchase of investment securities (1,201) Purchase of property, plant and equipment 1,199,286) Purchase of intangible assets (29,544) Payments for guarantee deposits 14,593) Net cash provided by (used in) investing activities 1,244,626) Cash flows from financing activities Proceeds from long-term loans payable 1,120,000 Repayments of long-term loans payable 681,938) Repayments of lease obligations 3,639) Purchase of treasury shares (475) Cash dividends paid 164,120) Net cash provided by (used in) financing activities 269,826 Effect of exchange rate change on cash and cash equivalents (12,337) Net increase (decrease) in cash and cash equivalents 424,154 Cash and cash equivalents at beginning of 1,171,593 Cash and cash equivalents at end of 1,595,747 6